Vaclavik Daniella, Bechor Michele, Foster Adriana, Gralnik Leonard M, Bar-Haim Yair, Pine Daniel S, Bikson Marom, Silverman Wendy K, Reeb-Sutherland Bethany C, Pettit Jeremy W
Florida International University, Miami, Florida, USA.
Tel Aviv University, Tel Aviv, Israel.
Klin Spec Psihol. 2020;9(3):105-126. doi: 10.17759/cpse.2020090308.
This article presents the results of a case series to assess the feasibility, acceptability, and clinical promise of transcranial Direct Current Stimulation (tDCS) as an augmentation strategy in clinic referred adolescents. Attention Bias Modification Treatment (ABMT) is a computer-based attention-training protocol designed to reduce rapidly deployed attention orienting to threat and thereby reduce anxiety symptom severity. Studies of ABMT reveal overall small to medium effect sizes. Advances in the neural underpinnings of attention to threat and attention-training protocols suggest the potential of tDCS of the dorsolateral prefrontal cortex (dlPFC) as a novel augmentation strategy to enhance ABMT's efficacy (ABMT + tDCS). However, tDCS has never been tested in a sample of adolescents with anxiety disorders. Six adolescents with a primary anxiety disorder completed all four ABMT + tDCS sessions. Adverse effects were mild and transient. Adolescents and parents independently reported fair to excellent levels of satisfaction. Impairment ratings of the primary anxiety disorder significantly decreased. Further, electrophysiological data recorded via electroencephalography (EEG) suggested decreases in neural resources allocated to threat. These findings support the feasibility, acceptability, and clinical promise of tDCS as an augmentation strategy in adolescents with anxiety disorders, and provide the impetus for further investigation using randomized controlled designs in larger samples.
本文介绍了一个病例系列的结果,以评估经颅直流电刺激(tDCS)作为一种增效策略在临床转诊青少年中的可行性、可接受性和临床前景。注意偏向矫正治疗(ABMT)是一种基于计算机的注意力训练方案,旨在减少对威胁的快速部署注意力定向,从而降低焦虑症状的严重程度。对ABMT的研究显示总体效应大小为小到中等。对威胁的注意力和注意力训练方案的神经基础研究进展表明,背外侧前额叶皮层(dlPFC)的tDCS作为一种新型增效策略增强ABMT疗效(ABMT+tDCS)的潜力。然而,tDCS从未在患有焦虑症的青少年样本中进行过测试。六名患有原发性焦虑症的青少年完成了所有四次ABMT+tDCS治疗。不良反应轻微且短暂。青少年和家长分别报告了中等到高度的满意度。原发性焦虑症的损伤评分显著降低。此外,通过脑电图(EEG)记录的电生理数据表明,分配给威胁的神经资源减少。这些发现支持了tDCS作为焦虑症青少年增效策略的可行性、可接受性和临床前景,并为在更大样本中使用随机对照设计进行进一步研究提供了动力。